Anti-brain protein autoantibodies are detectable in extraparenchymal but not parenchymal neurocysticercosis

J Neuroimmunol. 2020 Jul 15:344:577234. doi: 10.1016/j.jneuroim.2020.577234. Epub 2020 Apr 6.

Abstract

Neurocysticercosis (NC) presents a spectrum of clinical manifestations, with two broad clinical entities based on the central nervous system location of the parasite: extraparenchymal (EP-NC) and parenchymal (P-NC). In this work, using quantitative immunoblot methodology, we demonstrate the presence of autoantibodies to brain proteins in CSF from EP-NC, but not P-NC, patients. There was striking correlation between the level of autoantibodies and the levels of the secreted metacestode glycoprotein HP-10, suggesting that the level of stimulation of the autoantibody response may be a function of the number of viable parasites. Nine corresponding proteins autoantigens were provisionally identified by mass spectroscopy.

Keywords: Anti-brain autoantibodies; Autoantigens; Extraparenchymal; HP-10; Neurocysticercosis; Parenchymal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Autoantibodies / cerebrospinal fluid*
  • Biomarkers / cerebrospinal fluid
  • Brain / metabolism*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurocysticercosis / cerebrospinal fluid*
  • Neurocysticercosis / diagnosis*
  • Parenchymal Tissue / metabolism*
  • Young Adult

Substances

  • Autoantibodies
  • Biomarkers